Brain injury biomarkers and applications in neurological diseases.
10.1097/CM9.0000000000003061
- Author:
Han ZHANG
1
;
Jing WANG
1
;
Yang QU
1
;
Yi YANG
1
;
Zhen-Ni GUO
1
Author Information
1. Stroke Center, Department of Neurology, the First Hospital of Jilin University, Changchun, Jilin 130021, China.
- Publication Type:Review
- MeSH:
Humans;
Biomarkers/cerebrospinal fluid*;
Nervous System Diseases/diagnosis*;
Brain Injuries/metabolism*;
Phosphopyruvate Hydratase/cerebrospinal fluid*;
Glial Fibrillary Acidic Protein/blood*;
S100 Calcium Binding Protein beta Subunit/blood*;
tau Proteins/cerebrospinal fluid*;
Ubiquitin Thiolesterase/blood*;
Myelin Basic Protein/cerebrospinal fluid*;
Neurofilament Proteins/blood*;
MicroRNAs/blood*;
Brain Injuries, Traumatic/metabolism*
- From:
Chinese Medical Journal
2025;138(1):5-14
- CountryChina
- Language:English
-
Abstract:
Neurological diseases are a major health concern, and brain injury is a typical pathological process in various neurological disorders. Different biomarkers in the blood or the cerebrospinal fluid are associated with specific physiological and pathological processes. They are vital in identifying, diagnosing, and treating brain injuries. In this review, we described biomarkers for neuronal cell body injury (neuron-specific enolase, ubiquitin C-terminal hydrolase-L1, αII-spectrin), axonal injury (neurofilament proteins, tau), astrocyte injury (S100β, glial fibrillary acidic protein), demyelination (myelin basic protein), autoantibodies, and other emerging biomarkers (extracellular vesicles, microRNAs). We aimed to summarize the applications of these biomarkers and their related interests and limits in the diagnosis and prognosis for neurological diseases, including traumatic brain injury, status epilepticus, stroke, Alzheimer's disease, and infection. In addition, a reasonable outlook for brain injury biomarkers as ideal detection tools for neurological diseases is presented.
